Tilray Q1 Preview: Germany Could Drive Earnings Surprise

Last March, I initiated my coverage of Tilray Brands, Inc. (NASDAQ: TLRY ) with a buy rating in light of Germany's new cannabis law which made it easier for patients to receive medical cannabis products. While As a former managing editor at a financial media publication focused on mid and small caps, I am using my experience to present investment opportunities in undervalued companies. My experience, combined with my academic background in financial markets and institutions, allows me to bring thorough rese ...